SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-017663
Filing Date
2017-08-14
Accepted
2017-08-14 16:33:04
Documents
47
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q evok-10q_20170630.htm 10-Q 856662
2 EX-10.1 evok-ex101_478.htm EX-10.1 681312
3 EX-31.1 evok-ex311_10.htm EX-31.1 9583
4 EX-31.2 evok-ex312_8.htm EX-31.2 9863
5 EX-32.1 evok-ex321_7.htm EX-32.1 5022
6 EX-32.2 evok-ex322_9.htm EX-32.2 5239
7 GRAPHIC g201708141955203537544.jpg GRAPHIC 6151
  Complete submission text file 0001564590-17-017663.txt   4199142

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT evok-20170630.xml EX-101.INS 754064
9 XBRL TAXONOMY EXTENSION SCHEMA evok-20170630.xsd EX-101.SCH 31737
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE evok-20170630_cal.xml EX-101.CAL 16375
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE evok-20170630_def.xml EX-101.DEF 111242
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE evok-20170630_lab.xml EX-101.LAB 225067
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evok-20170630_pre.xml EX-101.PRE 177548
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36075 | Film No.: 171030695
SIC: 2834 Pharmaceutical Preparations